Receptor Occupancy Analysis with Flow Cytometry at MLM Medical Labs

Receptor Occupancy Analysis – Powering Precision with Flow Cytometry

Receptor Occupancy Analysis Powering Precision with Flow Cytometry At MLM Medical Labs, our flow cytometry service line includes receptor occupancy analysis—a critical tool for clinical trial sponsors investigating the efficacy of immunotherapies and targeted biologics. Our expertise in this area enables accurate measurement of how well investigational drugs bind to their intended receptors, providing essential […]

Receptor Occupancy Analysis – Powering Precision with Flow Cytometry Read More »

PBMC and Flow Cytometry in Immunotherapy Development

PBMCs and Flow Cytometry: Unlocking T-Cell Activation Insights for Immunotherapy Development

At MLM Medical Labs, PBMC isolations and flow cytometry succcessfully work hand-in-hand in drug discovery and development, particularly in immunology and immunotherapy research.  Following is a real-world example: PBMCs and Flow Cytometry : Evaluating T-Cell Activation in Immunotherapy Development Context A leading biopharma company is developing a checkpoint inhibitor targeting the PD-1/PD-L1 pathway for cancer

PBMCs and Flow Cytometry: Unlocking T-Cell Activation Insights for Immunotherapy Development Read More »

Biomarkers in Alzheimer's and Parkinson's Disease Research and Drug Discovery

Biomarkers in Alzheimer’s & Parkinson’s Disease Research

Comprehensive Biomarker Testing for Global Alzheimer’s Disease Trials At MLM Medical Labs, we bring 30 years of expertise in delivering comprehensive central and specialty lab support for complex global clinical trials, including Alzheimer’s and Parkinson’s Disease research. Cutting-Edge Biomarker Solutions  We offer a robust portfolio of neurodegeneration biomarkers, ensuring high-quality, reliable data to advance your

Biomarkers in Alzheimer’s & Parkinson’s Disease Research Read More »

Metabolic Dysfunction in Nonalcoholic Steatohepatitis (NASH) – MASH More Fitting Term

Unraveling the Connection: Metabolic Dysfunction in Nonalcoholic Steatohepatitis (NASH) – MASH Determined to be a More Fitting Term

by Katie Dineen, B.S. Biology, Business Development Manager, Preclinical Research Lab Introduction:  Nonalcoholic Steatohepatitis (NASH) is a progressive liver disease characterized by inflammation and liver cell damage. One crucial aspect contributing to the development and progression of NASH is metabolic dysfunction.   Understanding NASH:  NASH falls under the broader category of nonalcoholic fatty liver disease (NAFLD),

Unraveling the Connection: Metabolic Dysfunction in Nonalcoholic Steatohepatitis (NASH) – MASH Determined to be a More Fitting Term Read More »

PBMC Isolation and Processing in Preclinical and Clinical Trial Research at MLM Medical Labs

Unlock the Potential of PBMCs in Drug Discovery and Development with Our Specialized Lab Services

In the rapidly evolving landscape of biopharma, the need for precise, reliable, and scalable cellular resources has never been more critical. At MLM Medical Labs, we specialize in providing high-quality Peripheral Blood Mononuclear Cells (PBMCs) to support cutting-edge research and development across a variety of therapeutic areas. Why Partner with MLM?Our PBMC lab services are

Unlock the Potential of PBMCs in Drug Discovery and Development with Our Specialized Lab Services Read More »

Considerations for Conducting Clinical Studies on Metabolic Conditions

With the proliferation of metabolic-related diseases such as diabetes, biopharmaceutical companies are working to develop new therapies that address these conditions. Companies large and small are expending precious resources to find treatments for people who have developed diabetes to lessen the likelihood of serious complications such as diabetic retinopathy, coronary artery disease and stroke.

Considerations for Conducting Clinical Studies on Metabolic Conditions Read More »